These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3586881)

  • 1. Proton relaxation enhancement by manganese(III)TPPS4 in a model tumor system.
    Fiel RJ; Button TM; Gilani S; Mark EH; Musser DA; Henkelman RM; Bronskill MJ; van Heteren JG
    Magn Reson Imaging; 1987; 5(2):149-56. PubMed ID: 3586881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice.
    Ogan MD; Revel D; Brasch RC
    Invest Radiol; 1987 Oct; 22(10):822-8. PubMed ID: 3429177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the localization of manganese (III) mesotetra(4-sulfonatophenyl)porphine in mice bearing L1210 tumors.
    Fiel RJ; Mark E; Button T; Gilani S; Musser D
    Cancer Lett; 1988 May; 40(1):23-32. PubMed ID: 3370627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mn-TPPS4 in the diagnosis of malignant skin tumors. In vivo studies with high resolution magnetic resonance tomography in melanotic melanoma].
    Mäurer J; Strauss A; Ebert W; Bauer H; Schroeder RJ; Felix R
    Radiologe; 1999 May; 39(5):422-7. PubMed ID: 10384698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: experimental results.
    Mäurer J; Strauss A; Ebert W; Bauer H; Felix R
    Melanoma Res; 2000 Feb; 10(1):40-6. PubMed ID: 10711639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mn-TPPS4; a potential MRI contrast agent for localizing the normal aortic wall in rabbits].
    Kim SW; Kozuka T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):192-4. PubMed ID: 2362799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MnPcS4: a new MRI contrast enhancing agent for tumor localisation in mice.
    Saini SK; Jena A; Dey J; Sharma AK; Singh R
    Magn Reson Imaging; 1995; 13(7):985-90. PubMed ID: 8583877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic contrast-enhancing properties of manganese-mesoporphyrin and manganese-TPPS4. A comparative magnetic resonance imaging study in rats.
    Schmiedl UP; Nelson JA; Starr FL; Schmidt R
    Invest Radiol; 1992 Jul; 27(7):536-42. PubMed ID: 1644554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isointense model for the evaluation of tumor-specific MRI contrast agents.
    Button TM; Fiel RJ
    Magn Reson Imaging; 1988; 6(3):275-80. PubMed ID: 3398734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small animal imaging with a clinical magnetic resonance imager.
    Henkelman RM; van Heteren JG; Bronskill MJ
    Magn Reson Med; 1987 Jan; 4(1):61-6. PubMed ID: 3821479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution and stability of metalloporphyrin MRI contrast agents.
    Lyon RC; Faustino PJ; Cohen JS; Katz A; Mornex F; Colcher D; Baglin C; Koenig SH; Hambright P
    Magn Reson Med; 1987 Jan; 4(1):24-33. PubMed ID: 3821476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice.
    Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I
    Br J Cancer; 2001 Jun; 84(12):1681-5. PubMed ID: 11401324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anomalous relaxivity of Mn3+ (TPPS4).
    Koenig SH; Brown RD; Spiller M
    Magn Reson Med; 1987 Mar; 4(3):252-60. PubMed ID: 3574059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological effects of anionic meso-tetrakis (para-sulfonatophenyl) porphyrins modulated by the metal center. Studies in rat liver mitochondria.
    Pessoto FS; Inada NM; Nepomuceno Mde F; Ruggiero AC; Nascimento OR; Vercesi AE; Nantes IL
    Chem Biol Interact; 2009 Oct; 181(3):400-8. PubMed ID: 19631199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of a pH-sensitive contrast agent for NMR 1H imaging.
    Helpern JA; Curtis JC; Hearshen D; Smith MB; Welch KM
    Magn Reson Med; 1987 Sep; 5(3):302-5. PubMed ID: 3431400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paramagnetic macrocyclic complexes as contrast agents for MR imaging: proton nuclear relaxation rate enhancement in aqueous solution and in rat tissues.
    Jackels SC; Kroos BR; Hinson WH; Karstaedt N; Moran PR
    Radiology; 1986 May; 159(2):525-30. PubMed ID: 3961187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mn[III] uroporphyrin I: a novel metalloporphyrin contrast agent for magnetic resonance imaging.
    McMillan JH; Cox GG; Kimler BF; Spicer JS; Batnitzky S
    Magn Reson Imaging; 1991; 9(4):553-8. PubMed ID: 1779726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of meso-tetra(p-sulfophenyl)porphine in murine sarcoma virus-induced tumor-bearing mice.
    Carrano CJ; Tsutsui M; McConnell S
    Cancer Treat Rep; 1977 Oct; 61(7):1297-300. PubMed ID: 201378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast enhancement of PC-3 prostate cancer for magnetic resonance imaging: animal studies using tumor-localizing Mn-metalloporphyrin (THF-Mn-Asp).
    Suzuki T; Nakano K; Tomiyoshi K; Sakata I; Endo K; Yamanaka H
    J Urol; 1996 Nov; 156(5):1850-2. PubMed ID: 8863630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton relaxation enhancement in experimental brain tumors--in vivo NMR study of manganese(III)TPPS in rat brain gliomas.
    Bockhorst K; Höhn-Berlage M; Kocher M; Hossmann KA
    Magn Reson Imaging; 1990; 8(4):499-504. PubMed ID: 2392036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.